Praxis Precision Medicines (PRAX)
(Delayed Data from NSDQ)
$42.22 USD
-3.01 (-6.65%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $42.70 +0.48 (1.14%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
PRAX 42.22 -3.01(-6.65%)
Will PRAX be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for PRAX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PRAX
Praxis Precision Medicines, Inc. (PRAX) Reports Q4 Loss, Tops Revenue Estimates
IGM Biosciences, Inc. (IGMS) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
PRAX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Praxis Precision Medicines, Inc. (PRAX) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
Ensign Group (ENSG) Q4 Earnings and Revenues Beat Estimates
Praxis Precision Medicines, Inc. (PRAX) Reports Q3 Loss, Misses Revenue Estimates
Other News for PRAX
PRAX Fell Below 20 Day Moving Average on September 19
Crossed Above 20 Day Moving Average appears for PRAX after 2.73% move
Is PRAX ready to move higher? Directional Movement Crossover Bullish shows up after climbing 4.83%
PRAX Coverage Initiated by Jones Trading with Buy Rating | PRAX Stock News
H.C. Wainwright Remains a Buy on Praxis Precision Medicines (PRAX)